Spotfire Sells DecisionSite Platform to Microbia

genomeweb
360dx

Spotfire Sells DecisionSite Platform to Microbia

Apr 12, 2002

NEW YORK, April 12 - Spotfire is expected to announce on Monday that privately held biotech company Microbia has bought its DecisionSite software to help its anti-infective drug-discovery research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Invivoscribe Submits FLT3 Mutation Assay CDx to Japanese Regulators
African Pan-Genome Analysis Reveals Significant Non-Reference Genome Sequences
Myriad Genetics to Repurchase $50M in Shares From Bank of America
NSGC: Genetic Counseling Can Ease Fear, Increase Empowerment Among Heart Disease Patients
Two Pore Guys Receive $2.8M TB Dx Grant From Bill & Melinda Gates Foundation
Top Five Articles on GenomeWeb Last Week: Bio-Rad, Point-of-Care Dx, Early Cancer Detection, and More

The Scan

Shaken Identity

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Free-Ish

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

This Week in PLOS

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

Isolation Worries

An opinion piece at Bloomberg discusses China's stance on genomic research.

Main menu